Rosalind Advisors Inc's Q1 2025 13F: 7 new positions, 4 exits

Form 13F-HR for the quarter ended Mar 31, 2025 · filed May 14, 2025 · 31 reported positions · accession 0001622627-25-000027

What changed this quarter

Rosalind Advisors Inc's changes in reported equity positions, Q1 2025
Activity Security Weight before Weight now Change Shares Shares %
Exited CHIMERIX INC (CMRX) 5.7% — −5.7 pts −3.05M sh −100%
New IDEAYA BIOSCIENCES INC (IDYA) — 5.6% +5.6 pts +700K sh new
Increased VERASTEM INC (VSTM) 2.5% 7.8% +5.3 pts +1.74M sh +194%
New VIRIDIAN THERAPEUTICS INC (VRDN) — 3.9% +3.9 pts +595K sh new
Increased REPLIMUNE GROUP INC (REPL) 1.7% 4.0% +2.3 pts +590K sh +227%
Reduced OPTINOSE INC (OPTN) 3.2% 1.1% −2.0 pts −621K sh −71%
New NUVATION BIO INC (NUVB) — 2.1% +2.1 pts +2.45M sh new
New PHARVARIS N V (PHVS) — 1.7% +1.7 pts +224K sh new
Reduced XERIS BIOPHARMA HOLDINGS INC (XERS) 5.7% 6.7% +1.0 pts −609K sh −20%
Increased FENNEC PHARMACEUTICALS INC (FENC) 4.3% 5.3% +1.0 pts +523K sh +42%
Reduced VERONA PHARMA PLC (VRNA) 3.8% 3.1% −0.7 pts −50,000 sh −33%
Reduced TREVI THERAPEUTICS INC (TRVI) 2.4% 1.9% −0.5 pts −450K sh −42%
Increased DELCATH SYS INC (DCTH) 17.2% 14.1% −3.1 pts +250K sh +9%
New MIND MEDICINE MINDMED INC (MNMD) — 1.2% +1.2 pts +420K sh new
Reduced MEDIWOUND LTD (MDWD) 6.0% 3.8% −2.2 pts −121K sh −19%
New COGENT BIOSCIENCES INC (COGT) — 0.7% +0.7 pts +248K sh new
Reduced MYOMO INC (MYO) 10.4% 6.3% −4.1 pts −295K sh −10%
Exited CASSAVA SCIENCES INC (SAVA) 0.5% — −0.5 pts −417K sh −100%
Increased UROGEN PHARMA LTD (URGN) 5.0% 5.1% +0.1 pts +80,000 sh +9%
Reduced ALPHA COGNITION INC (ACOG) 0.8% 0.3% −0.5 pts −148K sh −59%
Increased TALPHERA INC (TLPH) 0.2% 0.5% +0.3 pts +1.39M sh +226%
New KURA ONCOLOGY INC (KURA) — 0.3% +0.3 pts +100K sh new
Increased OCULAR THERAPEUTIX INC (OCUL) 5.2% 4.4% −0.8 pts +90,000 sh +8%
Reduced INSPIREMD INC (NSPR) 3.5% 3.0% −0.6 pts −221K sh −9%
Increased COMPASS PATHWAYS PLC (CMPS) 1.4% 1.1% −0.3 pts +116K sh +16%
Exited OWLET INC (OWLT) 0.1% — −0.1 pts −49,441 sh −100%
Reduced BIOFRONTERA INC (BFRI) 0.5% 0.3% −0.2 pts −168K sh −21%
Exited RELMADA THERAPEUTICS INC (RLMD) 0.0% — 0.0 pts −100K sh −100%
Increased ABEONA THERAPEUTICS INC (ABEO) 5.4% 4.2% −1.2 pts +427 sh 0%
Reduced KIORA PHARMACEUTICALS INC (KPRX) 0.4% 0.4% −0.1 pts −496 sh 0%

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 63.5% of the equity book

Changes in the top 10 this quarter: VSTM entered · IDYA entered · REPL entered · MDWD left · CMRX left · SVRA left

# Security Weight before Weight now
1 DELCATH SYS INC (DCTH) 17.2% 14.1%
2 VERASTEM INC (VSTM) 2.5% 7.8% Entered the top 10
3 XERIS BIOPHARMA HOLDINGS INC (XERS) 5.7% 6.7%
4 MYOMO INC (MYO) 10.4% 6.3%
5 IDEAYA BIOSCIENCES INC (IDYA) 0.0% 5.6% Entered the top 10
6 FENNEC PHARMACEUTICALS INC (FENC) 4.3% 5.3%
7 UROGEN PHARMA LTD (URGN) 5.0% 5.1%
8 OCULAR THERAPEUTIX INC (OCUL) 5.2% 4.4%
9 ABEONA THERAPEUTICS INC (ABEO) 5.4% 4.2%
10 REPLIMUNE GROUP INC (REPL) 1.7% 4.0% Entered the top 10
— MEDIWOUND LTD (MDWD) 6.0% 3.8% Left the top 10
— CHIMERIX INC (CMRX) 5.7% 0.0% Left the top 10
— SAVARA INC (SVRA) 4.4% 3.6% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).

Option positions (puts and calls)

Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.

Activity Security Type Shares before Shares now Reported value
Exited CASSAVA SCIENCES INC (SAVA) Put 417K 0 $0
Exited BIOMEA FUSION INC (BMEA) Put 911K 0 $0
Exited CORMEDIX INC (CRMD) Call 184K 0 $0
Exited EDGEWISE THERAPEUTICS INC (EWTX) Put 238K 0 $0
Exited ISHARES TR (NYC) Put 200K 0 $0
Exited SPDR SER TR (BIL) Put 800K 0 $0
Exited NEUMORA THERAPEUTICS INC. (NMRA) Put 137K 0 $0
Exited RELMADA THERAPEUTICS INC (RLMD) Put 100K 0 $0
Exited SPDR SER TR (BIL) Call 1.4M 0 $0
Reduced INVESCO QQQ TR (QQQ) Put 100K 50,000 $374K
Reduced CANDEL THERAPEUTICS INC (CADL) Put 263K 15,800 $3.57K